3UCB
Crystal Structure of Multidrug Resistant HIV-1 Protease Clinical Isolate PR20 in Complex with Darunavir
Entity
| Entity ID | Chain ID | Description | Type | Chain length | Formula weight | Number of molecules | DB Name (Accession) | Biological source | Descriptive keywords |
| 1 | A, B (A, B) | Protease | polymer | 99 | 10766.5 | 2 | UniProt (P03367) Pfam (PF00077) | Human immunodeficiency virus 1 (HIV-1) | |
| 2 | C, D (A, B) | (3R,3AS,6AR)-HEXAHYDROFURO[2,3-B]FURAN-3-YL(1S,2R)-3-[[(4-AMINOPHENYL)SULFONYL](ISOBUTYL)AMINO]-1-BENZYL-2-HYDROXYPROPYLCARBAMATE | non-polymer | 547.7 | 2 | Chemie (017) | |||
| 3 | E, F (A, B) | water | water | 18.0 | 108 | Chemie (HOH) |
Sequence modifications
A, B: 1 - 99 (UniProt: P03367)
| PDB | External Database | Details |
|---|---|---|
| Lys 7 | Gln 507 | engineered mutation |
| Phe 10 | Leu 510 | engineered mutation |
| Val 13 | Ile 513 | engineered mutation |
| Val 15 | Ile 515 | engineered mutation |
| Asn 30 | Asp 530 | engineered mutation |
| Ile 32 | Val 532 | engineered mutation |
| Phe 33 | Leu 533 | engineered mutation |
| Asp 35 | Glu 535 | engineered mutation |
| Ile 36 | Met 536 | engineered mutation |
| Asn 37 | Ser 537 | engineered mutation |
| Val 47 | Ile 547 | engineered mutation |
| Leu 54 | Ile 554 | engineered mutation |
| Glu 58 | Gln 558 | engineered mutation |
| Val 62 | Ile 562 | engineered mutation |
| Pro 63 | Leu 563 | engineered mutation |
| Ala 67 | Cys 567 | engineered mutation |
| Val 71 | Ala 571 | engineered mutation |
| Val 84 | Ile 584 | engineered mutation |
| Asp 88 | Asn 588 | engineered mutation |
| Thr 89 | Leu 589 | engineered mutation |
| Met 90 | Leu 590 | engineered mutation |
| Ala 95 | Cys 595 | engineered mutation |
Sequence viewer
Contents of the asymmetric unit
| Polymers | Number of chains | 2 |
| Total formula weight | 21533.1 | |
| Non-Polymers* | Number of molecules | 2 |
| Total formula weight | 1095.3 | |
| All* | Total formula weight | 22628.4 |






